Trichomoniasis other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
 
Line 15: Line 15:
<br />
<br />


=== The Solana trichomonas assay (Quidel) ===
===The Solana trichomonas assay (Quidel)===
Another rapid test for the qualitative detection of ''T. vaginalis''  [[DNA]] and can yield results <40 minutes after specimen collection. This assay is FDA cleared for diagnosing ''T. vaginalis'' from female vaginal and urine specimens from [[asymptomatic]] and [[symptomatic]] women with [[sensitivity]] >98%, compared with [[NAAT]] for vaginal specimens, and >92% for [[urine]] specimens<ref name="urlSTI Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/treatment-guidelines/default.htm |title=STI Treatment Guidelines |format= |work= |accessdate=}}</ref>
Another rapid test for the qualitative detection of ''T. vaginalis''  [[DNA]] and can yield results <40 minutes after specimen collection. This assay is FDA cleared for diagnosing ''T. vaginalis'' from female vaginal and urine specimens from [[asymptomatic]] and [[symptomatic]] women with [[sensitivity]] >98%, compared with [[NAAT]] for vaginal specimens, and >92% for [[urine]] specimens<ref name="urlSTI Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/treatment-guidelines/default.htm |title=STI Treatment Guidelines |format= |work= |accessdate=}}</ref>
<br />
<br />


=== The Osom trichomonas rapid test (Sekisui Diagnostics) ===
===The Osom trichomonas rapid test (Sekisui Diagnostics)===
An [[antigen]]-detection [[test]] that uses immunochromatographic [[capillary]] flow dipstick technology by using clinician-obtained vaginal specimens. Results are available in approximately 10–15 minutes, with sensitivities of 82%–95% and specificity of 97%–100%, compared with wet mount, culture, and transcription-mediated amplification<ref name="urlSTI Treatment Guidelines" />
An [[antigen]]-detection [[test]] that uses immunochromatographic [[capillary]] flow dipstick technology by using clinician-obtained vaginal specimens. Results are available in approximately 10–15 minutes, with sensitivities of 82%–95% and specificity of 97%–100%, compared with wet mount, culture, and transcription-mediated amplification<ref name="urlSTI Treatment Guidelines" />


=== The Amplivue trichomonas assay (Quidel) ===
===The Amplivue trichomonas assay (Quidel)===
Another rapid test providing qualitative detection of ''T.'' ''vaginalis'' that has been FDA cleared for vaginal specimens from [[symptomatic]] and [[asymptomatic]] women, with [[sensitivity]] of 90.7% and [[specificity]] of 98.9%, compared with [[NAAT]]. <ref name="urlSTI Treatment Guidelines" />
Another rapid test providing qualitative detection of ''T.'' ''vaginalis'' that has been FDA cleared for vaginal specimens from [[symptomatic]] and [[asymptomatic]] women, with [[sensitivity]] of 90.7% and [[specificity]] of 98.9%, compared with [[NAAT]]. <ref name="urlSTI Treatment Guidelines" />


The Osom assay and the Affirm VP III test is not FDA cleared for use with specimens from men.<ref name="urlSTI Treatment Guidelines" />
The Osom assay and the Affirm VP III test is not FDA cleared for use with specimens from men.<ref name="urlSTI Treatment Guidelines" /><ref name="urlwww.cdc.gov">{{cite web |url=https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf |title=www.cdc.gov |format= |work= |accessdate=}}</ref>


==References==
==References==

Latest revision as of 14:35, 17 September 2021

Sexually transmitted diseases Main Page

Vaginitis Main Page

Trichomoniasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Trichomoniasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Trichomoniasis other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Trichomoniasis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Trichomoniasis other diagnostic studies

CDC on Trichomoniasis other diagnostic studies

Trichomoniasis other diagnostic studies in the news

Blogs on Trichomoniasis other diagnostic studies

Directions to Hospitals Treating Trichomoniasis

Risk calculators and risk factors for Trichomoniasis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Overview

Another diagnostic test that may be helpful in the diagnosis of trichomoniasis is the whiff test.[1]

Other diagnostic tests

Another diagnostic test that may be helpful in the diagnosis of trichomoniasis is the whiff test.

Whiff test

Vaginal infection with trichomonas vaginalis alters the vaginal pH from acidic to basic. The whiff test is based on the addition of 10% potassium hydroxide to vaginal secretions. Vaginal pH >4.5 gives off a strong, fishy odor based on the presence of amines.[1]


The Solana trichomonas assay (Quidel)

Another rapid test for the qualitative detection of T. vaginalis DNA and can yield results <40 minutes after specimen collection. This assay is FDA cleared for diagnosing T. vaginalis from female vaginal and urine specimens from asymptomatic and symptomatic women with sensitivity >98%, compared with NAAT for vaginal specimens, and >92% for urine specimens[2]

The Osom trichomonas rapid test (Sekisui Diagnostics)

An antigen-detection test that uses immunochromatographic capillary flow dipstick technology by using clinician-obtained vaginal specimens. Results are available in approximately 10–15 minutes, with sensitivities of 82%–95% and specificity of 97%–100%, compared with wet mount, culture, and transcription-mediated amplification[2]

The Amplivue trichomonas assay (Quidel)

Another rapid test providing qualitative detection of T. vaginalis that has been FDA cleared for vaginal specimens from symptomatic and asymptomatic women, with sensitivity of 90.7% and specificity of 98.9%, compared with NAAT. [2]

The Osom assay and the Affirm VP III test is not FDA cleared for use with specimens from men.[2][3]

References

  1. 1.0 1.1 Coleman JS, Gaydos CA, Witter F (2013). "Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies". Obstet Gynecol Surv. 68 (1): 43–50. doi:10.1097/OGX.0b013e318279fb7d. PMC 3586271. PMID 23322080.
  2. 2.0 2.1 2.2 2.3 "STI Treatment Guidelines".
  3. "www.cdc.gov" (PDF).


Template:WH Template:WS